Enrique Diaz retweeted
Compartimos consenso LATAM del @Grupo_GELL
Second-line axicabtagene ciloleucel in large B-cell lymphoma ineligible for transplantation: ALYCANTE final analysis
onlinelibrary.wiley.com/doi/…
Enrique Diaz retweeted
La #SEHHPorElMundo 🇪🇸 en reunión del @Grupo_GELL #GELL2026: la Dra. Ana Marín participa en el simposio de “Actualizaciones de tratamiento en LNH” y nos habla del #linfoma del manto #HematologíaEnEspañol
Enrique Diaz retweeted
Un placer tenerte aquí en Panamá @SoniSmithMD ! @Grupo_GELL
Los adultos mayores con #linfoma tienen peores resultados que los adultos jóvenes. Una necesidad no cubierta : mejorar los tratamientos y garantizar el acceso. La brillante exposición de la Dra @SoniSmithMD en las jornadas de @Grupo_GELL #lymsm
Inclusion, brotherhood and networking overseas is the best and maybe only way to cure lymphoma. Muchas gracias @DrRaulCordoba por compartir tanta experiencia @Grupo_GELL @UTHealthSA @mayscancer
En GELL estamos absolutamente complacidos de tener a mi amigo y colega Chijioke Nze hablando para toda LATAM de ctDNA en Follicular Lymphoma, en espańol!! @Grupo_GELL @UTHealthSA @mayscancer @UTMDAnderson
linkedin.com/posts/vijornada… Maravillosa jornada y oportunidad de compartir nuestra experiencia de investigación con colegas de LATAM @UTHSAResearch @mayscancer @UTSA
Enrique Diaz retweeted
🚨 HOT OFF THE PRESS!!
Mapping the capacity for geriatric blood Cancer Care in Latin America: A cross-sectional survey of current status and future priorities
Outstanding leadership of @PerlaRcp in this project of #hematology & #geriheme in LatAm
share.google/mhI5AJ1MYtcDamb…
Enrique Diaz retweeted
Hematology-Oncology graduation.
Grateful to my mentors, family, friends and patients. It has been the most meaningful chapter of my life. On to the next one.
@LuisRaezMD @HemSandoval @OncoNerd @AEDiazMD @mazo_md @mgonzalezvelMD – at Pembroke Pines, FL
Enrique Diaz retweeted
Diferences in Outcomes for Elderly Patients with DLBCL Treated at Academic vs Community Programs: A 10-year Survival Analysis
#ASCO26 #MasseyCancerCenter
@VCUMassey @AEDiazMD #GELL @mayscancer
asco.org/abstracts-presentat…
Nothing more grateful than seeing my own mentees achieving very important milestones on career development!
Felicidades!! @UTHSAResearch @mayscancer
Enrique Diaz retweeted
Replying to @theglpman
What an honor to present an Oral Podium Presentation @ASCO. I want to thank @TheLongSOM, @mayscancer @UTHealthSA and my amazing support team @DrSukeshiArora, @KateIdaLathrop, Dr. Saba Shaikh,@LSOM_HemOnc, and my co-authors. This is also history making for San Salvador and the country of the Bahamas and Bahamian Cancer research @VisitTheBahamas, @MOHBahamas , @Moca_Foundation, @OurNewsRev @ewnewsbahamas! First Bahamian to Present Oral Podium at ASCO, and Proud @UWImona Alumni!
Enrique Diaz retweeted
Is it still ethical to treat patients with PCNSL without a BTKi?
Enrique Diaz retweeted
@Grupo_GELL somos una gran #familia. Hoy hemos incorporado a un nuevo miembro: Lymphoma Coalition (@knowyournodes). ¡¡Bienvenida @BolanosNat!! #linfoma #LatAm #hematología #HematologíaEnEspañol
Enrique Diaz retweeted
Deeply grateful for an incredible #ASH25
✅Met new colleagues
✅Reconnected with my lifelong mentor @AEDiazMD
✅4/4 abstracts selected for Achievement Awards
✅Celebrated with the amazing #TraineeCouncil members
✅Shared it all with my husband @e_toro123 and best friend @DocOncMD
Enrique Diaz retweeted
Our yearly now game of tennis before @SABCSSanAntonio @ErikaHamilton9 @KateIdaLathrop @jhaveri_komal @KariWisinski_MD @antgiorda @PTarantinoMD @RutaRaoMD
#SABCS25
The Academic Center as driver of improved OS in patients with Mycosis Fungoides @mayscancer #ASH25
Amazing collaborative effort @Grupo_GELL
Congratulations to Dr. Erin Kaser @UTHealthSA
Even classic HL, a potentially curable disease gets an OS benefit when treated in Academic Centers @mayscancer @UTHealthSA #ASH25 @Grupo_GELL
Location location location
Two Abstract Achievement Awards given to @laurareyesuribe in recognition to her contribution describing OS benefits when PMBCL and PEL patients are treated in Academic Centers @mayscancer @UTHealthSA #ASH25 @Grupo_GELL







































